Newron Pharmaceuticals SpA Financial Overview
Newron Pharmaceuticals SpA's market cap is currently $598.87M. The company's EPS TTM is $0; its P/E ratio is 6.81; Newron Pharmaceuticals SpA is scheduled to report earnings on September 16, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
